ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026
Globe Newswire•06/11/2026•16:05 ET
0
Key Highlights
- ➤Unaudited Q3 results due November 12, 2026, after market close
- ➤Conference call and webcast scheduled November 13, 2026, at 9:00 AM ET
- ➤Preliminary Q3 sales results expected to remain unchanged
- ➤Form 10-Q filing expected November 12, 2026, after market close
PORTLAND, Maine, Nov. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, expects to report unaudited financial results for the quarter ended September 30, 2026 after the market closes on Thursday, November 12, 2026.
The Company is planning to host a conference call and webcast on November 13, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties may access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international).
Get started
Create a free account to read the full story.